Sector: Artificial Intelligence

Latest content

Patenting AI: the nature of inventorship and the mechanics of ownership

Under English law, there is considerable uncertainty as to whether an AI program can be regarded as an inventor of a patent. Such ambiguity means that contracts between parties are crucial to regulating patent ownership

09 February 2022

The EPO and UKIPO approaches to AI and patentable subject matter

Co-published - Although the UK is a member of the European Patent Organisation, there are ways in which the two agencies differ in how they look at granting protection in the field

18 January 2022

Rise of AI continues to re-write life sciences IP strategies in 2022

A spate of pharma-high tech innovation partnerships have dominated opening days of the year

11 January 2022

Convergence leads tech trends IP strategists say are re-shaping innovation

The IAM Strategy 300 Global Leaders share the macro developments having the biggest impact on their clients

05 January 2022

The biggest Asia-Pacific IP stories of 2021

Beyond China, there was a lot going on in a market that is home to some of the world’s most important patent-producing businesses

21 December 2021

Google and Samsung top the list of applicants for AI-related patents at the EPO

Co-published – In-depth analysis of the data undertaken by Frances Wilding of Haseltine Lake Kempner, shows that applications and grants are on the rise, and that inventions cover a wide range of technologies

16 December 2021

Validity rate for Chinese patents ticks upward, but patent owners in top tech areas face tough road

While more than half of invention patents survive invalidation unscathed, key life science and communications classes see higher knock-out rate

06 December 2021

Australia under-invests in IP, and recent government proposals will not fix that

Saturday Opinion: In-house leaders say a mooted patent box regime limited to life sciences will reward companies that get patents already, failing to encourage IP investment in new industries

04 December 2021

Data monetisation drives Sanofi’s $180 million investment in AI biotech Owkin

The deal shows how privacy and silo barriers to the commercialisation of information are being overcome

29 November 2021

USPTO rejections: post-Alice insights

Featured in Special Report 2021 Q4: IP5 insights

29 November 2021

• <
• 1
• ...
• 2
• 3
• 4
• 5
• ...
• 6
• 7
• 8
• 9
• 10
• ...
• >